高级检索
当前位置: 首页 > 详情页

Therapeutic effect of compound of White Peony Root Oral Liquids on radiation-induced esophageal toxicity via the expression of EGF and TGF-β1.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Internal Medicine, The First Hospital of the Hebei Medical University, Shijiazhuang, Hebei 050031 [2]Department of Biotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011 [3]Centre of Scientific Research, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011 [4]Centre of HMO Administrator of Shijiazhuang, The First Hospital of the Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China.
出处:
ISSN:

摘要:
The predominant pathological processes of radiation-induced esophageal toxicity include inflammatory reactions in the early stage and the fibrotic process in the late stage. An increased expression of the epidermal growth factor (EGF) and transforming growth factor β1 (TGF-β1) is capable of reducing inflammatory reactions and TGF-β1 is considered responsible for the initiation, development and persistence of fibrosis. In the present study, we investigated in vivo the therapeutic effect of the compound of white peony root oral liquids (cWPROL) on reducing the toxicity via modulating the expression levels of EGF and TGF-β1. Adult male Wistar rats were treated and tissue sections were obtained. The tissue sections were stained using histological, Masson and immunohistochemical staining. The results revealed that cWPROL had a higher rate of repairing damaged structures compared with the control group. In addition, immunohistochemistry showed that although cWPROL and the mixture of lidocaine, dexamethasone and gentamycin (mLDG) induced levels of EGF and TGF-β1 expression, there were differences between the two types of intervention. These results are significant for understanding that the mechanism of therapeutic effect of cWPROL varied to some extent from that of mLDG.

基金:
语种:
PubmedID:
中科院分区:
出版当年[2013]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
第一作者:
第一作者机构: [1]Department of Internal Medicine, The First Hospital of the Hebei Medical University, Shijiazhuang, Hebei 050031
通讯作者:
通讯机构: [2]Department of Biotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011 [*1]Department of Biotherapy, The Fourth Hospital of Hebei Medical University, 12 Jian Kang Road, Shijiazhuang, Hebei 050011, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号